AU Patent

AU2019403368A1 — Compositions, devices, and methods for the treatment of overdose and reward-based disorders

Assigned to Indivior UK Ltd · Expires 2021-07-29 · 5y expired

What this patent protects

Drug products adapted for nasal delivery, comprising a device filled with a pharmaceutical composition comprising naltrexone are provided. Formulations and methods of treating alcohol use disorder and related conditions with the drug products are also provided.

USPTO Abstract

Drug products adapted for nasal delivery, comprising a device filled with a pharmaceutical composition comprising naltrexone are provided. Formulations and methods of treating alcohol use disorder and related conditions with the drug products are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019403368A1
Jurisdiction
AU
Classification
—
Expires
2021-07-29
Drug substance claim
No
Drug product claim
No
Assignee
Indivior UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.